Expanding the glycoengineering toolbox: The rise of bacterial N-linked protein glycosylation

Trends in Biotechnology

Volumn 31, Issue 5, 2013, Pages 313-323

  Baker, Jenny L ^a   Çelik, Eda ^a,b   DeLisa, Matthew P ^a  

^a Cornell University   (United States)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Bioorthogonal chemical reporters; Biopharmaceuticals; Glycoconjugates; Glycoproteins; Post translational modification; Therapeutics and vaccines

Indexed keywords

BIOORTHOGONAL CHEMICAL REPORTERS; BIOPHARMACEUTICALS; GLYCOCONJUGATES; N-LINKED GLYCOSYLATION; POST-TRANSLATIONAL MODIFICATIONS; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATIONS; THERAPEUTIC POTENTIALS;

AMINO ACIDS; CHEMICAL MODIFICATION; ESTERIFICATION; GLYCOPROTEINS; GLYCOSYLATION; RECOMBINANT PROTEINS; VACCINES;

BACTERIA;

BACTERIAL GLYCOENGINEERING; BACTERIUM; BIOTECHNOLOGY; EUKARYOTE; GLYCOSYLATION; NONHUMAN; PRIORITY JOURNAL; PROKARYOTE; REVIEW; SPECIES DIVERSITY;

BACTERIA; BACTERIAL PROTEINS; BIOTECHNOLOGY; GLYCOPROTEINS; GLYCOSYLATION; METABOLIC ENGINEERING;

BACTERIA (MICROORGANISMS); HARNESS;

EID: 84876722082     PISSN: 01677799     EISSN: 18793096     Source Type: Journal    
DOI: 10.1016/j.tibtech.2013.03.003     Document Type: Review

References (92)

1. Apweiler R., et al. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim. Biophys. Acta 1999, 1473:4-8.
2. Zielinska D.F., et al. Mapping N-glycosylation sites across seven evolutionarily distant species reveals a divergent substrate proteome despite a common core machinery. Mol. Cell 2012, 46:542-548.
3. Sethuraman N., Stadheim T.A. Challenges in therapeutic glycoprotein production. Curr. Opin. Biotechnol. 2006, 17:341-346.
4. Schwarz F., Aebi M. Mechanisms and principles of N-linked protein glycosylation. Curr. Opin. Struct. Biol. 2011, 21:576-582.
5. Helenius A., Aebi M. Roles of N-linked glycans in the endoplasmic reticulum. Annu. Rev. Biochem. 2004, 73:1019-1049.
6. Helenius A., Aebi M. Intracellular functions of N-linked glycans. Science 2001, 291:2364-2369.
7. Varki A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 1993, 3:97-130.
8. Agard N.J., Bertozzi C.R. Chemical approaches to perturb, profile, and perceive glycans. Acc. Chem. Res. 2009, 42:788-797.
9. Sola R.J., Griebenow K. Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy. BioDrugs 2010, 24:9-21.
10. Sola R.J., Griebenow K. Effects of glycosylation on the stability of protein pharmaceuticals. J. Pharm. Sci. 2009, 98:1223-1245.
11. Werner A., et al. Glycoengineering the N-acyl side chain of sialic acid of human erythropoietin affects its resistance to sialidase. Biol. Chem. 2012, 393:777-783.
12. Sinclair A.M., Elliott S. Glycoengineering: the effect of glycosylation on the properties of therapeutic proteins. J. Pharm. Sci. 2005, 94:1626-1635.
13. Macdougall I.C. Optimizing the use of erythropoietic agents - pharmacokinetic and pharmacodynamic considerations. Nephrol. Dial. Transplant. 2002, 17(Suppl. 5):66-70.
14. Friedman B., et al. A comparison of the pharmacological properties of carbohydrate remodeled recombinant and placental-derived beta-glucocerebrosidase: implications for clinical efficacy in treatment of Gaucher disease. Blood 1999, 93:2807-2816.
15. Rothman R.J., et al. Antibody-dependent cytotoxicity mediated by natural killer cells is enhanced by castanospermine-induced alterations of IgG glycosylation. Mol. Immunol. 1989, 26:1113-1123.
16. LaTemple D.C., et al. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase. Cancer Res. 1999, 59:3417-3423.
17. Feldman M.F., et al. Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:3016-3021.
18. Ihssen J., et al. Production of glycoprotein vaccines in Escherichia coli. Microb. Cell Fact. 2010, 9:61.
19. Valderrama-Rincon J.D., et al. An engineered eukaryotic protein glycosylation pathway in Escherichia coli. Nat. Chem. Biol. 2012, 8:434-436.
20. Szymanski C.M., et al. Evidence for a system of general protein glycosylation in Campylobacter jejuni. Mol. Microbiol. 1999, 32:1022-1030.
21. Nothaft H., Szymanski C.M. Protein glycosylation in bacteria: sweeter than ever. Nat. Rev. Microbiol. 2010, 8:765-778.
22. Jervis A.J., et al. Characterization of the structurally diverse N-linked glycans of Campylobacter species. J. Bacteriol. 2012, 194:2355-2362.
23. Scott N.E., et al. Simultaneous glycan-peptide characterization using hydrophilic interaction chromatography and parallel fragmentation by CID, HCD and ETD-MS applied to the N-linked glycoproteome of Campylobacter jejuni. Mol. Cell. Proteomics 2011, 10. M000031-MCP201-1-M000031-MCP201-18.
24. Nothaft H., et al. N-Linked protein glycosylation in Campylobacter. Campylobacter 2008, 447-469. ASM. 3rd edn. I. Nachamkin (Ed.).
25. Linton D., et al. Identification of N-acetylgalactosamine-containing glycoproteins PEB3 and CgpA in Campylobacter jejuni. Mol. Microbiol. 2002, 43:497-508.
26. Wacker M., et al. N-Linked glycosylation in Campylobacter jejuni and its functional transfer into E. coli. Science 2002, 298:1790-1793.
27. Young N.M., et al. Structure of the N-linked glycan present on multiple glycoproteins in the Gram-negative bacterium, Campylobacter jejuni. J. Biol. Chem. 2002, 277:42530-42539.
28. Fisher A.C., et al. Production of secretory and extracellular N-linked glycoproteins in Escherichia coli. Appl. Environ. Microbiol. 2011, 77:871-881.
29. Çelik E., et al. A filamentous phage display system for N-linked glycoproteins. Protein Sci. 2010, 19:2006-2013.
30. Durr C., et al. The Escherichia coli glycophage display system. Glycobiology 2010, 20:1366-1372.
31. Schwarz F., et al. Cytoplasmic N-glycosyltransferase of Actinobacillus pleuropneumoniae is an inverting enzyme and recognizes the NX(S/T) consensus sequence. J. Biol. Chem. 2011, 286:35267-35274.
32. Power P.M., et al. Pilin glycosylation in Neisseria meningitidis occurs by a similar pathway to wzy-dependent O-antigen biosynthesis in Escherichia coli. Biochem. Biophys. Res. Commun. 2006, 347:904-908.
33. Aas F.E., et al. Neisseria gonorrhoeae O-linked pilin glycosylation: functional analyses define both the biosynthetic pathway and glycan structure. Mol. Microbiol. 2007, 65:607-624.
34. Power P.M., et al. Genetic characterization of pilin glycosylation and phase variation in Neisseria meningitidis. Mol. Microbiol. 2003, 49:833-847.
35. Vik A., et al. Broad spectrum O-linked protein glycosylation in the human pathogen Neisseria gonorrhoeae. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:4447-4452.
36. Henderson G.E., et al. Site-specific modification of recombinant proteins: a novel platform for modifying glycoproteins expressed in E. coli. Bioconjug. Chem. 2011, 22:903-912.
37. Dube D.H., et al. Chemical tools to discover and target bacterial glycoproteins. Chem. Commun. (Camb.) 2011, 47:87-101.
38. Reid C.W., et al. Never take candy from a stranger: the role of the bacterial glycome in host-pathogen interactions. Future Microbiol. 2010, 5:267-288.
39. Balonova L., et al. Bioanalytical tools for the discovery of eukaryotic glycoproteins applied to the analysis of bacterial glycoproteins. Expert Rev. Proteomics 2009, 6:75-85.
40. Jervis A.J., et al. Characterization of N-linked protein glycosylation in Helicobacter pullorum. J. Bacteriol. 2010, 192:5228-5236.
41. Szymanski C.M., Wren B.W. Protein glycosylation in bacterial mucosal pathogens. Nat. Rev. Microbiol. 2005, 3:225-237.
42. Reis C.A., et al. Alterations in glycosylation as biomarkers for cancer detection. J. Clin. Pathol. 2010, 63:322-329.
43. Lundström S.L., et al. Application of capillary electrophoresis mass spectrometry and liquid chromatography multiple-step tandem electrospray mass spectrometry to profile glycoform expression during Haemophilus influenzae pathogenesis in the chinchilla model of experimental otitis media. Infect. Immun. 2008, 76:3255-3267.
44. van Sorge N.M., et al. N-Glycosylated proteins and distinct lipooligosaccharide glycoforms of Campylobacter jejuni target the human C-type lectin receptor MGL. Cell. Microbiol. 2009, 11:1768-1781.
45. Ielmini M.V., Feldman M.F. Desulfovibrio desulfuricans PglB homolog possesses oligosaccharyltransferase activity with relaxed glycan specificity and distinct protein acceptor sequence requirements. Glycobiology 2011, 21:734-742.
46. Nothaft H., et al. Diversity in the protein N-glycosylation pathways within the Campylobacter genus. Mol. Cell. Proteomics 2012, 11:1203-1219.
47. Kelly J., et al. A novel N-linked flagellar glycan from Methanococcus maripaludis. Carbohydr. Res. 2009, 344:648-653.
48. Scott N.E., et al. Modification of the Campylobacter jejuni N-linked glycan by EptC protein-mediated addition of Phosphoethanolamine. J. Biol. Chem. 2012, 287:29384-29396.
49. Mariño K., et al. A systematic approach to protein glycosylation analysis: a path through the maze. Nat. Chem. Biol. 2010, 6:713-723.
50. Katrlík J., et al. Glycan and lectin microarrays for glycomics and medicinal applications. Med. Res. Rev. 2010, 30:394-418.
51. Oyelaran O., Gildersleeve J.C. Glycan arrays: recent advances and future challenges. Curr. Opin. Chem. Biol. 2009, 13:406-413.
52. Liang C.H., Wu C.Y. Glycan array: a powerful tool for glycomics studies. Expert Rev. Proteomics 2009, 6:631-645.
53. Ihssen J., et al. Structural insights from random mutagenesis of Campylobacter jejuni oligosaccharyltransferase PglB. BMC Biotechnol. 2012, 12:67.
54. Glover K.J., et al. In vitro assembly of the undecaprenylpyrophosphate-linked heptasaccharide for prokaryotic N-linked glycosylation. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:14255-14259.
55. Olivier N.B., et al. In vitro biosynthesis of UDP-N,N'-diacetylbacillosamine by enzymes of the Campylobacter jejuni general protein glycosylation system. Biochemistry 2006, 45:13659-13669.
56. Guarino C., DeLisa M.P. A prokaryote-based cell-free translation system that efficiently synthesizes glycoproteins. Glycobiology 2012, 22:596-601.
57. Lizak C., et al. X-ray structure of a bacterial oligosaccharyltransferase. Nature 2011, 474:350-355.
58. Jaffee M.B., Imperiali B. Exploiting topological constraints to reveal buried sequence motifs in the membrane-bound N-linked oligosaccharyl transferases. Biochemistry 2011, 50:7557-7567.
59. Terra V.S., et al. Recent developments in bacterial protein glycan coupling technology and glycoconjugate vaccine design. J. Med. Microbiol. 2012, 61:919-926.
60. Iwashkiw J.A., et al. Exploiting the Campylobacter jejuni protein glycosylation system for glycoengineering vaccines and diagnostic tools directed against brucellosis. Microb. Cell Fact. 2012, 11:13.
61. Wetter M., et al. Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component. Glycoconj. J. 2012, 10.1007/s10719-012-9451-9.
62. Schwarz F., et al. A combined method for producing homogeneous glycoproteins with eukaryotic N-glycosylation. Nat. Chem. Biol. 2010, 6:264-266.
63. Hug I., et al. Exploiting bacterial glycosylation machineries for the synthesis of a Lewis antigen-containing glycoprotein. J. Biol. Chem. 2011, 286:37887-37894.
64. Focareta A., et al. A recombinant probiotic for treatment and prevention of cholera. Gastroenterology 2006, 130:1688-1695.
65. Paton A.W., et al. Recombinant probiotics for treatment and prevention of enterotoxigenic Escherichia coli diarrhea. Gastroenterology 2005, 128:1219-1228.
66. Ilg K., et al. Glycomimicry: display of the GM3 sugar epitope on Escherichia coli and Salmonella enterica sv Typhimurium. Glycobiology 2010, 20:1289-1297.
67. Paton A.W., et al. Neutralization of shiga toxins Stx1, Stx2c, and Stx2e by recombinant bacteria expressing mimics of globotriose and globotetraose. Infect. Immun. 2001, 69:1967-1970.
68. Mally M., et al. Glycoengineering of host mimicking type-2 LacNAc polymers and Lewis X antigens on bacterial cell surfaces. Mol. Microbiol. 2013, 87:112-131.
69. Yavuz E., et al. Glycomimicry: display of fucosylation on the lipo-oligosaccharide of recombinant Escherichia coli K12. Glycoconj. J. 2011, 28:39-47.
70. Wang Z., et al. Hexosamine analogs: from metabolic glycoengineering to drug discovery. Curr. Opin. Chem. Biol. 2009, 13:565-572.
71. Dumont A., et al. Click-mediated labeling of bacterial membranes through metabolic modification of the lipopolysaccharide inner core. Angew. Chem. Int. Ed. Engl. 2012, 51:3143-3146.
72. Liu F., et al. The engineering of bacteria bearing azido-pseudaminic acid-modified flagella. Chembiochem 2009, 10:1317-1320.
73. Koenigs M.B., et al. Metabolic profiling of Helicobacter pylori glycosylation. Mol. Biosyst. 2009, 5:909-912.
74. Elliott S., et al. Enhancement of therapeutic protein in vivo activities through glycoengineering. Nat. Biotechnol. 2003, 21:414-421.
75. Rich J.R., Withers S.G. Emerging methods for the production of homogeneous human glycoproteins. Nat. Chem. Biol. 2009, 5:206-215.
76. Çelik E., Calik P. Production of recombinant proteins by yeast cells. Biotechnol. Adv. 2012, 30:1108-1118.
77. Lizak C., et al. N-Linked glycosylation of antibody fragments in Escherichia coli. Bioconjug. Chem. 2011, 22:488-496.
78. Skretas G., et al. Expression of active human sialyltransferase ST6GalNAcI in Escherichia coli. Microb. Cell Fact. 2009, 8:50.
79. Pandhal J., et al. Systematic metabolic engineering for improvement of glycosylation efficiency in Escherichia coli. Biochem. Biophys. Res. Commun. 2012, 419:472-476.
80. Williams G.J., et al. Recombinant E. coli prototype strains for in vivo glycorandomization. ACS Chem. Biol. 2011, 6:95-100.
81. Unnikrishnan M., et al. Recombinant bacterial vaccines. Curr. Opin. Immunol. 2012, 24:337-342.
82. Larkin A., Imperiali B. The expanding horizons of asparagine-linked glycosylation. Biochemistry 2011, 50:4411-4426.
83. Mohorko E., et al. Oligosaccharyltransferase: the central enzyme of N-linked protein glycosylation. J. Inherit. Metab. Dis. 2011, 34:869-878.
84. Kumar M., Balaji P.V. Comparative genomics analysis of completely sequenced microbial genomes reveals the ubiquity of N-linked glycosylation in prokaryotes. Mol. Biosyst. 2011, 7:1629-1645.
85. Kowarik M., et al. Definition of the bacterial N-glycosylation site consensus sequence. EMBO J. 2006, 25:1957-1966.
86. Wacker M., et al. Substrate specificity of bacterial oligosaccharyltransferase suggests a common transfer mechanism for the bacterial and eukaryotic systems. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:7088-7093.
87. Kowarik M., et al. N-Linked glycosylation of folded proteins by the bacterial oligosaccharyltransferase. Science 2006, 314:1148-1150.
88. Reid C.W., et al. Characterization of lipid-linked oligosaccharides by mass spectrometry. Methods Mol. Biol. 2010, 600:187-197.
89. Reid C.W., et al. Analysis of bacterial lipid-linked oligosaccharide intermediates using porous graphitic carbon liquid chromatography-electrospray ionization mass spectrometry: heterogeneity in the polyisoprenyl carrier revealed. Anal. Chem. 2009, 81:8472-8478.
90. Hitchen P.G., Dell A. Bacterial glycoproteomics. Microbiology 2006, 152:1575-1580.
91. Reid C.W., et al. Affinity-capture tandem mass spectrometric characterization of polyprenyl-linked oligosaccharides: tool to study protein N-glycosylation pathways. Anal. Chem. 2008, 80:5468-5475.
92. Hitchen P.G., et al. Glycoproteomics: a powerful tool for characterizing the diverse glycoforms of bacterial pilins and flagellins. Biochem. Soc. Trans. 2010, 38:1307-1313.